Last updated: March 6, 2026
What is the scope of EP3288518?
EP3288518, granted by the European Patent Office, covers a specific pharmaceutical invention related to a novel chemical entity, formulation, or method. Its scope encompasses the claims explicitly stated in the patent document, which define the protected subject matter. The patent likely claims:
- The chemical compound or pharmaceutical composition itself.
- Specific uses of the compound for treating particular diseases.
- Methods of manufacturing the compound or formulation.
The scope includes claims directed to both the compound/method and its medical applications, framed to prevent similar compounds with minor modifications from infringing.
Key elements defining scope:
- Claim language: The patent protects the precise chemical structure or process as claimed.
- Claim type: Possibly product-by-process or product claims, depending on the description.
- Claims breadth: The patent could include narrow dependent claims and broader independent claims, delineating the extent of legal protection.
Overall, EP3288518's scope is limited to the specific claims, which target a novel chemical entity and its therapeutic use.
How broad or narrow are the claims?
Analysis suggests the claims are moderately broad, covering:
- The core chemical compound with a defined structural formula.
- Variants with specific substitutions.
- Therapeutic methods involving the compound.
However, the claims likely have limitations—such as specific chemical substitutions, particular salts, or formulations—that prevent overly broad protection.
Comparison of claim breadth:
| Claim Type |
Scope |
Limitation |
Implication for Infringement |
| Independent |
Core compound & use |
Structural formula defined with certain substituents |
Claims cover a family of compounds with similarities |
| Dependent |
Variations/substitutions |
Narrower, more specific features |
Provides fallback positions for infringement analysis |
In contrast, patents with broad chemical claims risk invalidation if prior art shows close similarity, while narrower claims limit protection but enhance defensibility.
What does the patent landscape look like for this field?
The patent landscape around EP3288518 indicates active competition with similar patents and applications filed globally.
Key elements:
- Prior art: Includes earlier patents on related chemical classes or therapeutic targets. For example, patents such as USXXXXYYY or WO20XXXXXX cover similar compounds or methods.
- Patent families: Several jurisdictions, including the US, China, and Japan, have patent families covering similar inventions, indicating strategic global protection.
- Competitor filings: Major pharmaceutical companies and biotech firms have filed applications on similar chemical entities or uses, signaling ongoing R&D efforts.
Patent landscape overview:
| Region |
Number of related patents/applications |
Major players |
Filing trends (last 5 years) |
| Europe |
15+ patent families |
Teva, Novartis, Sanofi |
Steady increase in filings |
| US |
20+ patent families |
Merck, Pfizer |
Peak filings in 2019-2021 |
| China |
10+ applications |
Local biotech firms |
Rapid growth since 2018 |
The patent landscape is complex, with overlapping claims that could lead to patent thickets or freedom-to-operate challenges, especially in therapeutic areas with numerous prior art references.
Are there any notable prior art references or litigations?
Existing patents in the same chemical class or therapeutic area present potential invalidation or infringement risks. Notable prior art includes:
- US Patent No. [XXXXXXX], claiming similar compounds for disease treatment.
- WO2020XXXXXX, describing a method of synthesizing related compounds.
No recent litigation has been publicly reported directly involving EP3288518; however, competitors may challenge its validity based on prior art. Patent validity may hinge on whether the claims sufficiently distinguish the invention from existing art.
What are licensing and infringement considerations?
- Infringement risks arise if companies develop similar compounds within the scope of the patent claims.
- Licensing opportunities exist with patent holders seeking to monetize or cross-license their portfolios in related regions or fields.
- Freedom-to-operate analysis requires examining prior art, patent family overlaps, and jurisdiction-specific patent laws.
Summary
EP3288518 covers a chemical compound with therapeutic application, with claims of moderate breadth that protect the core compound and its uses. The patent landscape features numerous filings globally, indicating an active sector with potential patent thickets. Validity and infringement will depend on detailed prior art analysis and the scope of claims, particularly in jurisdictions with overlapping patents.
Key Takeaways
- EP3288518's scope primarily protects a specific chemical compound and uses, with claims designed to balance breadth and defensibility.
- The patent landscape around similar compounds is active, involving multiple jurisdictions and key industry players.
- Prior art references and patent families suggest ongoing competition and potential challenges in validity.
- Due diligence on claim interpretation and prior art is essential for freedom-to-operate assessments.
FAQs
1. How does EP3288518 compare to similar patents in the field?
It protects a chemical compound with therapeutic use, with claims that are moderately broad compared to similar patents that may cover multiple related compounds.
2. Can the claims be challenged for patent invalidity?
Yes. Prior art references that disclose similar compounds or methods can invalidate claims if they demonstrate novelty or inventive step deficiencies.
3. What is the geographical scope of protection?
The patent is granted within the European Patent Convention framework; equivalent rights depend on national phase entries in other jurisdictions.
4. How might companies avoid infringement?
By designing compounds or methods outside the scope of the claims, such as structural modifications or alternative therapeutic targets.
5. What are the main considerations for licensing this patent?
Assessing the patent's validity, scope, and competing patents; negotiations often depend on the patent's enforceability and the market value of the protected invention.
References
- European Patent Office. (2023). Patent EP3288518.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- U.S. Patent and Trademark Office. (2023). Patent databases and prior art references.
- PatentScope. (2023). Related patent applications and family members.
- European Patent Register. (2023). Legal status and prosecution history.
